Grünenthal on Expanding Pain Treatment Access Across Asia-Pacific

Biopharma Boardroom speaks with Quentin Le Masne de Chermont, Head of Corporate Strategy and Business Development at Grünenthal Group, a...

October 13, 2026 | Tuesday | Interview
Foresee’s CAMCEVI Wins NMPA Approval in Advanced Prostate Cancer

Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced that it was notified by its licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd. (...

October 13, 2026 | Tuesday | News
FDA Grants Fast Track Status to Leads Biolabs’ Opamtistomig in Biliary Tract Cancer

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that the U.S. Food and Drug Admin...

October 13, 2026 | Tuesday | News
Encaleret Improves Symptoms and Bone Turnover in Phase 3 ADH1 Study

- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1 - 100% of participants w...

October 13, 2026 | Tuesday | News
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing in the US

Biopharma Boardroom speaks with Nadia Aelbrecht, Vice President, Head of Infectious Disease at QIAGEN, about rapid diagnostics, antimicrobial...

October 12, 2026 | Monday | Interview
Alumis Reports 48-Week Phase 3 Data for Envudeucitinib in Plaque Psoriasis

Results build on ONWARD3 highest complete skin clearance (54% PASI 100) at Week 48, reinforcing envudeucitinib’s potential to become a leading oral...

October 12, 2026 | Monday | News
Everest Medicines Strengthens mRNA Team with Two Former Moderna Executives

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & ...

October 12, 2026 | Monday | News
Ribo Submits EU Phase 1 Trial Application for Obesity Drug RBD3133

Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the successful submission...

October 09, 2026 | Friday | News
Neurosterix Completes Phase 1 Study of NTX-253 for Schizophrenia

Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allos...

October 09, 2026 | Friday | News
Andelyn Biosciences and PQP Group Partner on EU and UK Gene Therapy Supply

Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization (...

October 09, 2026 | Friday | News
Systech Launches ST15S and ST16P Packaging Systems for Pharmaceutical Production

Systech, a global leader in pharmaceutical serialization and traceability, announced the availability of two new integrated packaging solutions designed to...

October 09, 2026 | Friday | News
CHARM Therapeutics Begins Phase I/II Trial of CHM-029 for Acute Myeloid Leukaemia

CHARM Therapeutics (“CHARM”, “The Company”), a clinical-stage biotechnology company addressing resistance in acute myeloid leukemia...

October 08, 2026 | Thursday | News
Lakewood-Amedex Reports Positive Preclinical Data for Bisphosphocin Antimicrobials

Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting,...

October 08, 2026 | Thursday | News
Cerevance Reports Positive Phase 3 Results for Solengepras in Parkinson’s Disease

Solengepras 150 mg achieved a statistically significant reduction in daily OFF time, with benefit seen at Week 2 Statistically significant improvements ...

October 08, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close